These observations and experiments, as well as many others, provide insights into the contribution of sphingolipids in gastric cancer development, providing important information for potential early therapeutic anti-SphK and anti-S1PR intervention targets in the prevention of metastasis in gastric cancers. The gene discussed is SPHK1; the disease is gastric cancer.